Table 4 : Summary of cases with tumor recurrence.


Age (Years) Sex Risk factors Location   Size (cm) Brain infiltration WHO Grade Ki67 LI   PR Extent of Resection Adjuvant treatment F/U (yr) ECOG at last F/U

5 F None ST   6.5 - I -   Unk GTR None 1 Unknown
30 M TR ACF   2.9 Yes II 10   + STR SRT 5 2
30 F None ST   3.1 No II 5   + GTR SRT / SRS 0.25 2
27 M None ACF, MCF,
PCF
  4 - II -   Unk STR Unknown Unknown Unknown
20 F None ACF,
MCF
  - - II 20   + STR None 4 Unknown
29 M ER ACF   8 Yes I 2   + GTR SRT / SRS 7 0
27 F None ACF, MCF,
PCF
  1 No I -   Unk STR SRT 7 2
24 M Previous radiation ACF,
MCF
  5 No II 10   + STR SRT 6 1
17 F None ACF   4 No I 7   + GTR None 8 1
30 M TR ST   2.9 No I 5   + GTR None 6 0
30 F None ACF   - No I -   Unk GTR None 6 0
30 M None ACF   - Unk I Unk   Unk STR None - Unknown

(M:Male, F:Female, ST:Supratentorial, SB:Skull base, Unk:Unknown, WHO:World Health Organization, PR:Progesterone receptor, SRT:Stereotactic radiotherapy, SRS:Stereotactic radiosurgery, F/U:Followup, ECOG:Eastern cooperative oncology group)

Prabhu et al.Neuroscience Discovery  2014 2:1DOI : 10.7243/2052-6946-2-1